Cancer, mood, anxiety, sleep: it’s all connected and yoga eases symptoms for survivors
Meeting Announcement
CMCC and Politecnico di Milano will host the 4th International Conference on Carbon Dioxide Removal (CDR) on June 10–12, 2026, in Milan, Italy. The conference provides a platform for a vibrant global network of scholars and practitioners working to better understand the opportunities, risks, and governance challenges associated with carbon removal.
City of Hope researchers showcased new advances at ASCO 2026, highlighting progress in targeted therapies, microbiome science and blood cancers, with emerging findings in kidney, liver and prostate cancers underscoring a move toward more personalized, biology-driven treatment approaches.
Researchers from Mass General Brigham Cancer Institute will present research discoveries and outcomes from clinical trials in cancer at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, held May 29 – June 2, in Chicago
ASCO brings together leading experts in clinical oncology to share the latest breakthroughs in cancer research, science and medicine. Presentations from Mass General Brigham Cancer Institute investigators include a study evaluating the outcomes of patients admitted to a dedicated oncology service within a multisite home hospital program; the results of a late-breaking plenary session on prostate cancer; efficacy and safety of a lung cancer drug; the efficacy of an app to support the psychosocial needs of patients with multiple myeloma; the creation of an electronic frailty index to inform risk ahead of CAR-T cell therapy treatments, and more.
Below are a few highlights from this year’s presentations. All times are Central Time (CT).
Researchers can register and submit abstracts for the first joint meeting hosted by the Endocrine Society and Keystone Symposia—an intimate meeting designed to bring together researchers to advance understanding of how hormonal signaling shapes cancer risk, progression and treatment response.